• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

避孕禁忌的最新情况。

Update on the contraceptive contraindications.

作者信息

Serfaty D

机构信息

Hôpital St Louis, 75010, Paris, France.

出版信息

J Gynecol Obstet Hum Reprod. 2019 May;48(5):297-307. doi: 10.1016/j.jogoh.2019.02.006. Epub 2019 Feb 20.

DOI:10.1016/j.jogoh.2019.02.006
PMID:30796985
Abstract

BACKGROUND

The choice of contraceptive methods has considerably increased over recent years. However, all available methods are not appropriate for all women, especially those with medical conditions or individual characteristics in whom any pregnancy, particularly unintended pregnancy, is at higher risk. The safety of contraception is crucial for these women and evidence-based guidance to help healthcare providers choosing a suitable method has been published. The aim of our review is to make an update on the main contraceptive contraindications.

METHODS

The World Health Organisation Medical Eligibility Criteria for Contraceptive Use (WHO-MEC) published in 2015 are referred to throughout this review. The rationale behind the recommendations for women with cardiovascular, rheumatic, neurologic, gynaecological or endocrine disorders was first analysed. The national adaptations of the WHO-MEC, especially the French, British, and American ones, were then scrutinized.

MAIN FINDINGS

Overall, the MECs considered tend to provide the same recommendations. However, there are some noticeable differences that may be useful to know. Hence, for a given condition, differences in categorisation have been noticed where limited or controversial scientific evidence relating to this condition exists, especially regarding hormonal contraceptives. Some medical conditions or characteristics, included in some MECs but not in others, have also been identified.

CONCLUSION

MECs represent valuable tools to help clinicians to prescribe the most acceptable and safe contraceptive method for each individual woman. Although it may be useful to consult different MECs for some complex conditions, prescribers should always bear in mind that these MECs are only guidelines and that their clinical judgment should always prevail.

摘要

背景

近年来,避孕方法的选择大幅增加。然而,并非所有可用方法都适用于所有女性,尤其是那些有健康问题或个人特征的女性,她们怀孕的风险更高,尤其是意外怀孕。避孕安全对这些女性至关重要,已发布基于证据的指南以帮助医疗保健提供者选择合适的方法。我们综述的目的是更新主要的避孕禁忌证。

方法

本综述通篇参考了2015年发布的世界卫生组织《避孕方法医学适用标准》(WHO-MEC)。首先分析了针对患有心血管、风湿、神经、妇科或内分泌疾病女性的建议背后的基本原理。然后仔细审查了WHO-MEC的各国改编版本,尤其是法国、英国和美国的版本。

主要发现

总体而言,所考虑的医学适用标准往往提供相同的建议。然而,存在一些值得注意的差异,了解这些差异可能会有所帮助。因此,对于某一特定情况,在存在与该情况相关的有限或有争议的科学证据时,尤其是关于激素避孕法,已注意到分类上的差异。还确定了一些医学状况或特征,它们在某些医学适用标准中有,但在其他标准中没有。

结论

医学适用标准是帮助临床医生为每位女性开出最可接受和安全的避孕方法的宝贵工具。尽管对于某些复杂情况参考不同的医学适用标准可能有用,但开处方者应始终牢记,这些医学适用标准只是指南,临床判断应始终占主导地位。

相似文献

1
Update on the contraceptive contraindications.避孕禁忌的最新情况。
J Gynecol Obstet Hum Reprod. 2019 May;48(5):297-307. doi: 10.1016/j.jogoh.2019.02.006. Epub 2019 Feb 20.
2
Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.在有雌激素使用禁忌证的育龄妇女中使用复方激素避孕法。
Am J Obstet Gynecol. 2016 Sep;215(3):330.e1-7. doi: 10.1016/j.ajog.2016.03.047. Epub 2016 Apr 5.
3
Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period.更新至 2010 年 CDC 的美国避孕方法医学标准:产后使用避孕方法的修订建议。
MMWR Morb Mortal Wkly Rep. 2011 Jul 8;60(26):878-83.
4
ACOG Practice Bulletin. The use of hormonal contraception in women with coexisting medical conditions. Number 18, July 2000.美国妇产科医师学会实践公告。合并内科疾病女性使用激素避孕法。2000年7月第18号。
Int J Gynaecol Obstet. 2001 Oct;75(1):93-106. doi: 10.1016/s0020-7292(01)00520-3.
5
Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.《美国疾病控制与预防中心(CDC)2016年避孕方法医学适用标准更新:针对HIV感染高危女性使用激素避孕的修订建议》
MMWR Morb Mortal Wkly Rep. 2017 Sep 22;66(37):990-994. doi: 10.15585/mmwr.mm6637a6.
6
Contraceptive choices in women with coagulation disorders.凝血功能障碍女性的避孕选择
Am J Obstet Gynecol. 1993 Jun;168(6 Pt 2):1990-3. doi: 10.1016/s0002-9378(12)90940-0.
7
Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV.美国疾病预防控制中心(CDC)避孕方法医学资格标准更新:修订感染艾滋病毒或艾滋病毒高危妇女使用激素避孕方法的建议。
MMWR Morb Mortal Wkly Rep. 2012 Jun 22;61(24):449-52.
8
Progestin-only oral contraception: a comprehensive review.仅含孕激素的口服避孕药:全面综述
Contraception. 1994 Dec;50(6 Suppl 1):S1-195.
9
Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.《加拿大避孕共识》(共四部分之第三部分):第7章——宫内避孕法
J Obstet Gynaecol Can. 2016 Feb;38(2):182-222. doi: 10.1016/j.jogc.2015.12.002. Epub 2016 Feb 26.
10
Breast cancer among young U.S. women in relation to oral contraceptive use.美国年轻女性乳腺癌与口服避孕药使用的关系。
J Natl Cancer Inst. 1994 Apr 6;86(7):505-14. doi: 10.1093/jnci/86.7.505.

引用本文的文献

1
": A qualitative study of women's perceptions and experiences of medical reasons for non-preferred contraceptive use.:一项关于女性对非首选避孕方法使用的医学原因的认知与经历的定性研究。
Womens Health (Lond). 2025 Jan-Dec;21:17455057251358983. doi: 10.1177/17455057251358983. Epub 2025 Jul 28.
2
Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review.乳腺癌患者及高危女性脱发治疗的安全性:综述
Am J Clin Dermatol. 2025 Jul 8. doi: 10.1007/s40257-025-00961-9.
3
Non-hormonal Contraception: Current and Emerging Targets.
非激素避孕:当前及新出现的靶点
Adv Exp Med Biol. 2025;1469:245-272. doi: 10.1007/978-3-031-82990-1_11.
4
Modern contraceptive utilization and associated factors among street working reproductive age women in Ethiopia: A systematic review and meta-analysis.埃塞俄比亚街头工作的育龄妇女的现代避孕方法使用情况及相关因素:一项系统评价与荟萃分析
PLoS One. 2024 Dec 27;19(12):e0312569. doi: 10.1371/journal.pone.0312569. eCollection 2024.
5
Assessment of contraceptive methods choice among women during childbearing age in Mosul, Iraq.伊拉克摩苏尔育龄妇女避孕方法选择的评估
Saudi Med J. 2024 Dec;45(12):1368-1373. doi: 10.15537/smj.2024.45.12.20240565.
6
Brazilian Guideline on Menopausal Cardiovascular Health - 2024.《巴西更年期心血管健康指南 - 2024》
Rev Bras Ginecol Obstet. 2024 Oct 15;46. doi: 10.61622/rbgo/2024rbgo100. eCollection 2024.
7
Knowledge, attitude and practice of puerperal adolescents after an educational intervention on the mini contraceptive pill.产后青少年接受迷你避孕药教育干预后的知识、态度和实践。
8
Brazilian Guideline on Menopausal Cardiovascular Health - 2024.《巴西更年期心血管健康指南 - 2024》
Arq Bras Cardiol. 2024 Aug 16;121(7):e20240478. doi: 10.36660/abc.20240478.
9
Client experiences with telehealth using LINE for consultation and assessment of adverse effects of contraceptive implants during the COVID-19 pandemic in Thailand.泰国在新冠疫情期间,客户使用LINE进行远程医疗咨询和评估避孕植入物不良反应的经历。
Digit Health. 2023 Sep 28;9:20552076231203877. doi: 10.1177/20552076231203877. eCollection 2023 Jan-Dec.
10
Crigler-Najjar type II in pregnancy: A case report.妊娠期克里格勒-纳贾尔综合征II型:一例报告。
Obstet Med. 2023 Sep;16(3):184-186. doi: 10.1177/1753495X221099443. Epub 2022 May 12.